Submission of Annual Secretarial Compliance Report for FY 2025-26
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudeep Pharma Limited has submitted its Annual Secretarial Compliance Report for FY 2025-26 as required under SEBI Regulation 24A. The report was issued by Practicing Company Secretary Hemang Mehta of H M Mehta & Associates. The company, which listed on stock exchanges on 28th November 2025, has reported full compliance with all applicable SEBI regulations including LODR, ICDR, SAST, and Insider Trading Regulations. One minor observation was noted: three instances where designated persons acquired equity shares during the trading window closure period during the exemption period for SDD framework implementation. The company has issued warning letters to the concerned designated persons. No deviations, penalties, or actions by SEBI or stock exchanges were reported.
Positive signal for shareholders as the company has maintained full regulatory compliance with no major violations. The minor trading window violations were proactively addressed by the company with warning letters, indicating adequate internal controls.